miRNA-Enhanced Nuclear Reprogramming Without c-Myc
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing induced pluripotent stem cells (iPS cells) through nuclear reprogramming are inefficient, particularly when excluding c-Myc, and face challenges with low production yields and potential tumorigenesis concerns, while also requiring the use of viral vectors which can be risky.
Innovation Solution
The use of specific microRNAs (miRNAs) such as mmu-miR-294, mmu-miR-295, hsa-miR-302-367 cluster, and others to enhance nuclear reprogramming efficiency in the absence of c-Myc and Sox2, by introducing these miRNAs along with nuclear reprogramming factors like Oct3/4 and Klf4 into somatic cells using retroviral vectors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If c-Myc is excluded from nuclear reprogramming factors, then tumorigenesis risk is reduced, but reprogramming efficiency deteriorates
Solution Approach 1:
The invention changes the parameter of reprogramming efficiency by introducing miRNAs as additional reprogramming factors. Instead of relying solely on the four classic transcription factors (Oct3/4, Sox2, Klf4, c-Myc), the patent adds miRNA molecules to the reprogramming cocktail, which significantly enhances the efficiency of somatic cell reprogramming to pluripotent stem cells while maintaining safety by excluding c-Myc.
Solution Approach 2:
The invention uses miRNAs as intermediary molecules that mediate the reprogramming process. These miRNAs act as bridges between the transcription factors and the target genes, facilitating efficient nuclear reprogramming. The miRNAs can be delivered through viral vectors or non-viral methods, serving as a crucial intermediary that enhances reprogramming without requiring c-Myc.
2Productivity
If traditional viral vectors are used for factor introduction, then reprogramming can be achieved, but safety and control deteriorate
Solution Approach 1:
The invention employs transient expression vectors that deliver reprogramming factors and miRNAs temporarily. These vectors (such as plasmids or adenoviruses) provide the necessary reprogramming molecules during the critical reprogramming window and then disappear, leaving no persistent viral genome in the host cell. This approach maintains reprogramming capability while improving safety and control compared to integrating viral vectors.
Data Source
AI summary
A method of preparing induced pluripotent stem cells, comprising a nuclear reprogramming step with a nuclear reprogramming factor in the presence of miRNA, wherein said miRNA has a property of providing a higher nuclear reprogramming efficiency in the presence of said miRNA than in the absence thereof.